For more information on Greenpeace campaigns related to the EU, please contact:

or at +32 (0)22 741 911

Alternatively, for urgent requests you can also contact:

at +31 (0)20 718 2470

Greenpeace photo and video: Please see copyright policy for information about use.

at +44 (0)207 865 8230

at +31 (0)20 718 2113

at +31 (0)6 461 62 015

at +31 (0)20 718 2115

For media enquiries on topics other than EU affairs, please contact the appropriate national Greenpeace office or Greenpeace International.

The latest updates

 

Greenpeace comment: EU vote on glyphosate extension

Press release | June 6, 2016 at 12:17

Brussels – The European Commission has failed to secure sufficient support from EU governments for its proposal to extend a licence for glyphosate by up to 18 months. The outcome shows that governments remain sceptical about the continued use of...

Commission seeks glyphosate approval by another name

Press release | June 1, 2016 at 10:15

Brussels – The European Commission is seeking political backing to allow unrestricted use of controversial weedkiller glyphosate by labelling the decision as temporary, warned Greenpeace.

Greenpeace comment on EU glyphosate decision

Press release | May 19, 2016 at 11:50

Brussels – An EU vote scheduled for today in Brussels on the re-approval of a controversial weedkiller known as glyphosate has reportedly been postponed.

Greenpeace comment on Commission’s proposal to fund nuclear research

Press release | May 17, 2016 at 10:30

Brussels – Following 'Der Spiegel' article [1] about a leaked new EU proposal to fund nuclear energy research, Greenpeace EU energy policy adviser Bram Claeys said:

Industry ties raise questions about UN body assessing glyphosate cancer risk

Press release | May 16, 2016 at 13:13

Brussels – The FAO /WHO Joint Meeting on Pesticide Residues (JMPR) released an assessment today, which concludes that the controversial weedkiller glyphosate is “unlikely to pose a carcinogenic risk to humans from exposure through the diet” [1].

11 - 15 of 625 results.